Li-Hong Liu (Lihong Liu)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Metabolic Syndrome

Top Venues

Disease markers

Journal of healthcare engineering

BMJ (Clinical research ed.)

This page only lists publications with an associated author ORCID identifier.

Publications

Yongchao Liang, Ying Zhu, Ying Zhang, Ziwei Chen, Boyang Li, Aijun Liu, Li-Hong Liu
Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma. Journal of healthcare engineering 2022 (2022)
Yuan Sun, Ling Cong, Song Yang, Rui Zhao, Zhuoling An, Li-Hong Liu
Moxifloxacin Induced Liver Injury by Causing Lachnospiraceae Deficiency and Interfering with Butyric Acid Production through Gut-Liver Axis. Disease markers 2022 (2022)
Lingling Xuan, Lulu Ren, Feifei Han, Lili Gong, Zirui Wan, Song Yang, He Liu, Yali Lv, Li-Hong Liu
Cytomegalovirus Infection Exacerbates Experimental Colitis by Promoting IL-23 Production. Inflammation 43 (1) (2020)
Ying Wang, Zhikang Ye, Long Ge, Reed A C Siemieniuk, Xin Wang, Yingkai Wang, Liangying Hou, Zhuo Ma, Thomas Agoritsas, Per Olav Vandvik, Anders Perner, Morten H Møller, Gordon H Guyatt, Li-Hong Liu
Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis. BMJ (Clinical research ed.) 368 (2020)
Li-Li Gong, Song Yang, Wen Zhang, Fei-Fei Han, Ling-Ling Xuan, Ya-Li Lv, He Liu, Li-Hong Liu
Targeted Metabolomics for Plasma Amino Acids and Carnitines in Patients with Metabolic Syndrome Using HPLC-MS/MS. Disease markers 2020 (2020)